Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026
Rhea-AI Summary
Bausch Health (NYSE:BHC) plans to release its second quarter 2026 financial results after market close on Wednesday, July 29, 2026.
The company will host a live conference call and webcast at 5:00 p.m. U.S. EDT, with materials available beforehand on its investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction – BHC
In the Jul 7 session, BHC gained 2.08%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 31 | earnings date announcement | Neutral | +7.4% | Set date and time for first quarter 2026 earnings release and call. |
| Jan 21 | earnings date announcement | Neutral | -2.1% | Announced schedule for Q4 and full-year 2025 earnings release and webcast. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Past earnings-date announcements have led to mixed one-day share moves, with no clear directional pattern.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LAVAL, QC, July 7, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2026 financial results after market close on Wednesday, July 29, 2026. Bausch Health will host a live conference call and webcast at 5:00 p.m. U.S. EDT to discuss results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Conference Call Details
Date: Wednesday, July 29, 2026
Time: 5:00 p.m. U.S. EDT
Webcast: http://ir.bauschhealth.com/events-and-presentations
A replay of the conference call will be available on the Investor Relations website.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.
Investor Contact: | Media Contact: |
Garen Sarafian | Katie Savastano |
(877) 281-6642 (toll-free) | (908) 541-3785 |
BHC-FINANCIAL |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-to-announce-second-quarter-2026-results-on-july-29-2026-302818447.html
SOURCE Bausch Health Companies Inc.
